Gentian

Gentian Diagnostics ASA is a publicly listed Norwegian in vitro diagnostics (IVD) company that develops and manufactures high-quality diagnostic reagents and test kits for use on clinical chemistry analysers. Founded in 1996 and headquartered in Moss, Norway, the company focuses on particle-enhanced turbidimetric immunoassay (PETIA) technology that enables efficient, automated testing on standard laboratory equipment. Its product portfolio covers kidney disease (Cystatin C, RBP), cardiac disease (NT-proBNP), inflammation and infection (Calprotectin/GCAL), and veterinary diagnostics (Canine CRP). Gentian serves the global market through OEM partnerships and distributors, and also operates regional entities in the Nordics, North America, and China.